Researchers from UC San Diego and Yale have developed and highlighted small nuclear RNA base editing as a safer alternative to traditional CRISPR-Cas9 gene editing, addressing concerns of off-target effects and unintended mutations. Separate studies showcased engineered prime editors with improved precision, reducing insertion and deletion errors during gene editing. These innovations hold promise to increase the safety and efficacy of gene and cell therapies for genetic and neurodevelopmental disorders.